Cargando…

Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment

BACKGROUND: Growing evidence has shown that the prognosis for colon cancer depends on changes in microenvironment. The purpose of this study was to elucidate the prognostic value of long noncoding RNAs (lncRNAs) related to immune microenvironment (IM) in colon cancer. METHODS: Single sample gene set...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yilin, Pan, Xiaoxian, Chen, Zhihua, Lin, Suyong, Shen, Zhanlong, Chen, Shaoqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684099/
https://www.ncbi.nlm.nih.gov/pubmed/34922547
http://dx.doi.org/10.1186/s12935-021-02342-8
_version_ 1784617547588435968
author Lin, Yilin
Pan, Xiaoxian
Chen, Zhihua
Lin, Suyong
Shen, Zhanlong
Chen, Shaoqin
author_facet Lin, Yilin
Pan, Xiaoxian
Chen, Zhihua
Lin, Suyong
Shen, Zhanlong
Chen, Shaoqin
author_sort Lin, Yilin
collection PubMed
description BACKGROUND: Growing evidence has shown that the prognosis for colon cancer depends on changes in microenvironment. The purpose of this study was to elucidate the prognostic value of long noncoding RNAs (lncRNAs) related to immune microenvironment (IM) in colon cancer. METHODS: Single sample gene set enrichment analysis (ssGSEA) was used to identify the subtypes of colon cancer based on the immune genomes of 29 immune signatures. Cox regression analysis identified a lncRNA signatures associated with immune infiltration. The Tumor Immune Estimation Resource database was used to analyze immune cell content. RESULTS: Colon cancer samples were divided into three subtypes by unsupervised cluster analysis. Cox regression analysis identified an immune infiltration-related 5-lncRNA signature. This signature combined with clinical factors can effectively improve the predictive ability for the overall survival (OS) of colon cancer. At the same time, we found that the expression of H19 affects the content of B cells and macrophages in the microenvironment of colon cancer and affects the prognosis of colon cancer. Finally, we constructed the H19 regulatory network and further analyzed the possible mechanisms. We found that knocking down the expression of H19 can significantly inhibit the expression of CCND1 and VEGFA. At the same time, the immunohistochemical assay found that the expression of CCND1 and VEGFA protein was significantly positively correlated with the infiltration of M2 type macrophages. CONCLUSION: The findings may help to formulate clinical strategies and understand the underlying mechanisms of H19 regulation. H19 may be a biomarker for targeted treatment of colon cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02342-8.
format Online
Article
Text
id pubmed-8684099
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86840992021-12-20 Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment Lin, Yilin Pan, Xiaoxian Chen, Zhihua Lin, Suyong Shen, Zhanlong Chen, Shaoqin Cancer Cell Int Primary Research BACKGROUND: Growing evidence has shown that the prognosis for colon cancer depends on changes in microenvironment. The purpose of this study was to elucidate the prognostic value of long noncoding RNAs (lncRNAs) related to immune microenvironment (IM) in colon cancer. METHODS: Single sample gene set enrichment analysis (ssGSEA) was used to identify the subtypes of colon cancer based on the immune genomes of 29 immune signatures. Cox regression analysis identified a lncRNA signatures associated with immune infiltration. The Tumor Immune Estimation Resource database was used to analyze immune cell content. RESULTS: Colon cancer samples were divided into three subtypes by unsupervised cluster analysis. Cox regression analysis identified an immune infiltration-related 5-lncRNA signature. This signature combined with clinical factors can effectively improve the predictive ability for the overall survival (OS) of colon cancer. At the same time, we found that the expression of H19 affects the content of B cells and macrophages in the microenvironment of colon cancer and affects the prognosis of colon cancer. Finally, we constructed the H19 regulatory network and further analyzed the possible mechanisms. We found that knocking down the expression of H19 can significantly inhibit the expression of CCND1 and VEGFA. At the same time, the immunohistochemical assay found that the expression of CCND1 and VEGFA protein was significantly positively correlated with the infiltration of M2 type macrophages. CONCLUSION: The findings may help to formulate clinical strategies and understand the underlying mechanisms of H19 regulation. H19 may be a biomarker for targeted treatment of colon cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02342-8. BioMed Central 2021-12-18 /pmc/articles/PMC8684099/ /pubmed/34922547 http://dx.doi.org/10.1186/s12935-021-02342-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Lin, Yilin
Pan, Xiaoxian
Chen, Zhihua
Lin, Suyong
Shen, Zhanlong
Chen, Shaoqin
Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
title Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
title_full Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
title_fullStr Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
title_full_unstemmed Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
title_short Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
title_sort prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684099/
https://www.ncbi.nlm.nih.gov/pubmed/34922547
http://dx.doi.org/10.1186/s12935-021-02342-8
work_keys_str_mv AT linyilin prognosticvalueandimmuneinfiltrationofnovelsignaturesincoloncancermicroenvironment
AT panxiaoxian prognosticvalueandimmuneinfiltrationofnovelsignaturesincoloncancermicroenvironment
AT chenzhihua prognosticvalueandimmuneinfiltrationofnovelsignaturesincoloncancermicroenvironment
AT linsuyong prognosticvalueandimmuneinfiltrationofnovelsignaturesincoloncancermicroenvironment
AT shenzhanlong prognosticvalueandimmuneinfiltrationofnovelsignaturesincoloncancermicroenvironment
AT chenshaoqin prognosticvalueandimmuneinfiltrationofnovelsignaturesincoloncancermicroenvironment